Browse by author
Lookup NU author(s): Dr John Drury, Dr John Fordham, Dr Harish Datta, Emeritus Professor Roger Francis, Dr Stephen Tuck
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Background Osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) play a critical role in the regulation of bone turnover, but the relative importance of these two cytokines in the pathogenesis of postmenopausal osteoporosis is controversial. Aim To investigate the relationship between circulating levels of OPG, RANKL, bone turnover and bone mineral density (BMD) in postmenopausal women. Methods A cross-sectional study of 185 women with osteoporosis and 185 age-and sex-matched control subjects was undertaken. Measurements were made of plasma OPG, RANKL, interleukin-6 (IL-6), sex steroids, calciotropic hormones, biochemical markers of bone turnover, BMD and anthropometry. Health questionnaires were administered. Results Plasma RANKL was significantly higher (p<0.0001) in women with osteoporosis (0.66 +/- 0.67 pmol/l) than in control subjects (0.37 +/- 0.38 pmol/l), as was plasma OPG (18.70 +/- 9.70 pmol/l in women with osteoporosis, 10.44 +/- 5.85 pmol/l in control subjects; p<0.0001). OPG/RANKL ratio was higher in women with osteoporosis (51.3) than in control subjects (36.6). The women with osteoporosis also had significantly higher biochemical markers of bone turnover, IL-6 and parathyroid hormone and lower 25-hydroxyvitamin D and oestradiol than the control subjects. Multiple regression analysis showed that lumbar spine and femoral neck BMD in postmenopausal women were best predicted by OPG and RANKL, giving an R-2 value of 15.5% and 14.9%, respectively. Conclusions This study indicates that the circulating levels of OPG and RANKL are inversely related to BMD and contribute to the development of osteoporosis in postmenopausal women.
Author(s): Francis RM; Datta HK; Fordham JN; Drury J; Tuck SP; Jabbar S
Publication type: Article
Publication status: Published
Journal: Journal of Clinical Pathology
Year: 2011
Volume: 64
Issue: 4
Pages: 354-357
Print publication date: 09/02/2011
ISSN (print): 0021-9746
ISSN (electronic): 1472-4146
Publisher: BMJ Group
URL: http://dx.doi.org/10.1136/jcp.2010.086595
DOI: 10.1136/jcp.2010.086595
Altmetrics provided by Altmetric
